Cargando…
Temsirolimus in overtreated metastatic renal cancer with subsequent use of sunitinib: A case report
During the last decade, we have been developing new therapeutic strategies for the treatment of renal cancer, based on knowledge derived from molecular biology. We report a case of long-term renal metastatic cancer progression despite therapy with sunitinib and interleukin, which are the most active...
Autores principales: | JURADO, JOSÉ MIGUEL, ZARCOS, IRENE, DELGADO, MAYTE, BLANCAS, ISABEL, LEGERÉN, MARTA, GARCÍA-PUCHE, JOSÉ LUIS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629020/ https://www.ncbi.nlm.nih.gov/pubmed/23599798 http://dx.doi.org/10.3892/ol.2013.1184 |
Ejemplares similares
-
Late relapse of non-seminomatous testicular cancer during treatment of multiple sclerosis with interferon β-1a: A case report
por: BLANCAS, ISABEL, et al.
Publicado: (2014) -
Efficacy and safety of aflibercept in metastatic colorectal cancer pretreated with bevacizumab: A report of five cases
por: Alcaide, Julia, et al.
Publicado: (2016) -
A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma
por: Ness, Dylan B., et al.
Publicado: (2023) -
Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma
por: Venugopal, Balaji, et al.
Publicado: (2013) -
Ductal carcinoma in situ (DCIS): are we overtreating it?
por: Dixon, JM
Publicado: (2004)